ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : nf-kb
Clear All
Filter by Field of Research
Cellular Immunology (6)
Orthopaedics (2)
Cell Development, Proliferation and Death (1)
Cell Physiology (1)
Haematology (1)
Innate Immunity (1)
Medical Virology (1)
Neurology And Neuromuscular Diseases (1)
Paediatrics (1)
Tumour Immunology (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (18)
Filter by Status
Closed (18)
Filter by Scheme
NHMRC Project Grants (6)
Early Career Fellowships (4)
Project Grants (3)
CARG - Research (2)
NHMRC Postgraduate Scholarships (2)
Research Fellowships (1)
Filter by Country
Australia (1)
Filter by Australian State/Territory
ACT (1)
  • Researchers (0)
  • Funded Activities (18)
  • Organisations (0)
  • Funded Activity

    The Role Of The NF-kB Pathway In Primary Mediastinal B Cell Lymphoma

    Funder
    National Health and Medical Research Council
    Funding Amount
    $335,244.00
    More information
    Funded Activity

    Characterization Of Host Cell Proteins That Modify The Growth Of The AIDS Virus

    Funder
    National Health and Medical Research Council
    Funding Amount
    $122,052.00
    More information
    Funded Activity

    Simvastatin Prevents Dopaminergic Neuronal Injury In Experimental PD Models Via Activation Of NF-kB And MMP 9 And 3

    Funder
    National Health and Medical Research Council
    Funding Amount
    $87,937.00
    Summary
    Increasing evidence shows that neuroinflammation may account for dopamine neuron death in Parkinson’s disease (PD). This work aims to provide systematic picture of inflammatory response in PD, and explore anti-inflammatory mechanisms of simvastatin on the progression of PD. We expect that the results may provide a therapeutic strategy using simvastatin via different methods of administration in treating PD, and provide new information about the anti-inflammatory roles of simvastatin.
    More information
    Funded Activity

    Host Cell Proteins That Control Viral And Cellular Gene Expression

    Funder
    National Health and Medical Research Council
    Funding Amount
    $181,410.00
    More information
    Funded Activity

    Investigating The Roles Of Non-coding RNAs In Inflammatory Signalling And Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $408,768.00
    Summary
    Inflammation occurs as part of the body's natural defenses against infection or injury, but can be damaging when unregulated and can lead to cancer. Although the protein factors critical for inflammation have been carefully studied it remains unknown how ribonucleic acid (RNA) molecules can modify and regulate inflammation. This project will identify RNA molecules that control inflammatory signalling, and further translate these findings to show they contribute to the progression of cancer.
    More information
    Funded Activity

    The Role Of Mal In Toll-like Receptor Signal Transduction Of The Pro-inflammatory Response.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $472,500.00
    Summary
    Sepsis kills more people per year than the cancers of the breast, colon, prostate and pancreas combined. Sepsis occurs in 1 of 50 hospital admissions and is the leading cause of death n intensive care units. The instance of sepsis has doubled in the last decade and is expected to increase. One of the major causes of sepsis si lipopolysaccharide (LPS), the main constituent of gram-negative bacteria's cell wall, and the prototypic inducer of the pro-inflammatory response of the innate immune syste .... Sepsis kills more people per year than the cancers of the breast, colon, prostate and pancreas combined. Sepsis occurs in 1 of 50 hospital admissions and is the leading cause of death n intensive care units. The instance of sepsis has doubled in the last decade and is expected to increase. One of the major causes of sepsis si lipopolysaccharide (LPS), the main constituent of gram-negative bacteria's cell wall, and the prototypic inducer of the pro-inflammatory response of the innate immune system. Dysregulation of the pro-inflammatory response can lead to sepsis. Recently, the mammalian receptor for LPS was found to be Toll-like receptor (TLR)-4, the activation of which activates a signal transduction pathway that initiates the pro-inflammatory response. We have previously shown a key role for an adapter protein called Mal in mediating signal transduction pathways upon activation of TLR-4. Interaction of Mal with a key signal transduction mediator called TRAF6 has been shown to induce the activation of the pro-inflammatory response. Furthermore, Mal has been found to undergo degradation which may indicate a means of regulating the continued activation of the pro-inflammatory pathway. This research program will investigate the role of Mal in mediating signal transduction in TLR activated macrophages, key responsive cells of the innate immune system to microbial infection. A greater understanding of these processes will assist in the development of therapeutics to alleviate the consequences of microbial-induced inflammation, including chronic inflammatory diseases and sepsis.
    Read more Read less
    More information
    Funded Activity

    Role Of SPPL2A On B Cell Survival And Antibody Production In Mice And Humans

    Funder
    National Health and Medical Research Council
    Funding Amount
    $592,989.00
    Summary
    B lymphocytes are a specialised type of blood cells that produce antibodies in response to a pathogen or a vaccine. We have recently discovered that all mature B cells depend for their survival on a previously unknown protein called SPPL2A. This application will investigate the molecular mechanism through which SPPL2A contributes to the survival of B cells. We will also investigate if humans with currently unexplained B cell deficiency have mutations in SPPL2A.
    More information
    Funded Activity

    Investigation And Modulation Of RANKL-induced Osteoclastogensis, Bone Resorption And Signaling Pathways

    Funder
    National Health and Medical Research Council
    Funding Amount
    $33,825.00
    Summary
    Osteoclasts are exclusively responsible for the degradation of bone matrix. RANKL is a member of a ligand-receptor system which directly regulates osteoclast differentiation and bone resorption. New treatment regime for various bone diseases have been highly sought after for many years. The identification of potential natural compounds that inhibit the formation and function of osteoclasts might serve as a useful tool for such treatment.
    More information
    Funded Activity

    Determining The Role Of Rel/NF-kB Transcription Factors In Myeloid Differentiation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $500,944.00
    Summary
    Different types of mature blood cells arise from stem cells in a process involving changes in gene expression that dictate which types of blood cells ultimately develop. A family of gene regulatory proteins called NF-kB transcription factors has been found to control the pattern of gene expression in a particular blood cell precursor called a granulocyte macrophage precursor (GMP) that normally generates two types of mature blood cells called macrophages and neutrophils. In the absence of NF-kB .... Different types of mature blood cells arise from stem cells in a process involving changes in gene expression that dictate which types of blood cells ultimately develop. A family of gene regulatory proteins called NF-kB transcription factors has been found to control the pattern of gene expression in a particular blood cell precursor called a granulocyte macrophage precursor (GMP) that normally generates two types of mature blood cells called macrophages and neutrophils. In the absence of NF-kB proteins, a change in the pattern of gene expression in GMPs leads to an imbalance in production of these two blood cell types that now favours the generation of neutrophils. This work will provide insight into the molecular mechanisms of blood cell development regulated by NF-kB. With disturbances in the balance of blood cell formation representing a hallmark of leukemia, understanding how this process is normally controlled may have important implications for developing therapeutic strategies to combat various types of leukemias.
    Read more Read less
    More information
    Funded Activity

    Innate Immune Responses To Rotavirus Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $534,200.00
    Summary
    Rotavirus is the main cause of severe diarrhoea in children worldwide. In this project, we aim to understand the nature of the first-line immune response to rotavirus in the gut, and elucidate how RV counteracts this response to promote infection. These studies will increase our understanding of how rotavirus causes disease, and facilitate the choice of rotavirus targets for drug development and improved vaccines.
    More information

    Showing 1-10 of 18 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback